Morph DNA BioCardia has announced that the FDA has granted 510(k) clearance for the Morph DNA deflectable guide catheter, which is used to guide the Helix biotherapeutic delivery system during CardiAMP cell therapy delivery in the heart. The Morph DNA deflectable guide catheter, a press release reports, is designed to enhance procedural [...]